Applying Prometheus To Myriad: Possible Outcomes

Law360, New York (May 21, 2012, 1:23 PM EDT) -- On March 26, 2012, the U.S. Supreme Court issued a much anticipated GVR (grant [certiorari], vacate and remand) order in the Association for Molecular Pathology v. the United States Patent Office (a.k.a. ACLU v. Myriad), remanding the case to the Federal Circuit for reevaluation in light of the Supreme Courts' recent decision in Mayo Medical Laboratories v. Prometheus Laboratories 566 U.S. ____ (US 2012). The Prometheus decision has been extensively discussed in the media but its possible impact on the Federal Circuit decision in Myriad has...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.